Skip to main content
BrainCited

Curcumin 用于 记忆力减退

C 证据 来自小型研究的证据有限,但存在一些积极信号。

Preclinical studies show memory enhancement with curcumin in Alzheimer's models. Human studies show limited but positive trends in working memory, primarily with enhanced bioavailability formulations.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dmemory\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

结论

Preclinical studies show memory enhancement with curcumin in Alzheimer's models. Human studies show limited but positive trends in working memory, primarily with enhanced bioavailability formulations.

Key Study Findings

In Vitro
Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium …
Dose: None vs: MitoQ (mitochondrial antioxidant) Outcome: Hippocampal bioenergetics and calcium homeostasis 效果: None None

研究人群: C57BL6 mice hippocampal slices (4-6 months old)

Review
Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic …
Dose: None vs: None Outcome: AD pathology modulation via LLPS and autophagy 效果: None None

研究人群: Alzheimer's disease (review of mechanisms)

In Vitro 4 weeks
Curcumin-enhanced stem cell exosomes: A novel approach to modulating neuroinflammation and improving cognitive function in …
Dose: 30 ug/body, 4 injections over 30 days vs: MSC-EXO alone; AD (STZ) rat model Outcome: Memory and neuroinflammation in AD rats 效果: None None

研究人群: STZ-induced AD male Wistar rats (250+/-50g)

In Vitro 4 weeks
Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum …
Dose: 100 mg/kg each vs: AlCl3-induced AD aged mice; individual high-dose Outcome: Cognitive deficits and neuroprotection 效果: None None

研究人群: 18-month old male Balb/c mice with AlCl3-induced AD

Other 8 weeks
Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male …
Dose: None vs: Vehicle-treated 5XFAD mice Outcome: Memory improvement and Aβ deposition in 5XFAD mice 效果: None None

研究人群: 5XFAD male Alzheimer's disease model mice

Key Statistics

8

研究数量

600

受试者

Mixed

C

等级

Referenced Papers

Current pharmaceutical biotechnology 2014 67 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
500-2,000 mg/day of enhanced bioavailability form
cognitivesupport:
90-180 mg/day Theracurmin or equivalent

上限: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

研究中使用的剂量

剂量 持续时间 效果 N
None -- Positive --
None -- Positive --
30 ug/body, 4 injections over 30 days 4 weeks Positive --
100 mg/kg each 4 weeks Positive --
None -- Mixed --
None 8 weeks Positive --
None -- Positive --
None -- Positive --

最佳服用时间: With meals containing fat and black pepper (piperine) for absorption

Safety & Side Effects

已报告的副作用

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Skin rash (rare)
  • Yellow staining of teeth with powder forms

已知相互作用

  • Anticoagulants (may increase bleeding risk)
  • Antidiabetic drugs (may enhance blood sugar lowering)
  • CYP450 substrates (may affect drug metabolism)
  • Iron supplements (curcumin may chelate iron)

可耐受最高摄入量: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Curcumin help with 记忆力减退?
Based on 8 studies with 600 participants, there is limited but promising evidence that Curcumin may support 记忆力减退 management. Our evidence grade is C (Some Evidence).
How much Curcumin should I take for 记忆力减退?
Studies have used various dosages. A commonly studied range is 500-2,000 mg/day of enhanced bioavailability form. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Skin rash (rare), Yellow staining of teeth with powder forms. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and 记忆力减退?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is mixed.

References

  1. [1] Mohammad-Ali Bashirrohelleh et al.. Eur J Pharmacol. 2025. Curcumin-enhanced stem cell exosomes: A novel approach to modulating neuroinflammation and improving cognitive function in a rat model of Alzheimer's … doi:10.1016/j.ejphar.2025.177695 PubMed
  2. [2] Mahsa Yavari et al.. Nutrients. 2025. Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids. doi:10.3390/nu17071203 PubMed
  3. [3] Nida Rasheed et al.. Exp Gerontol. 2025. Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged … doi:10.1016/j.exger.2024.112659 PubMed
  4. [4] Claudia Jara et al.. Neurotox Res. 2025. Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium Homeostasis. doi:10.1007/s12640-024-00726-y PubMed
  5. [5] Guifei Chen et al.. Food Sci Nutr. 2025. Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support. doi:10.1002/fsn3.70496 PubMed
  6. [6] Eunbi Cho et al.. Biomed Pharmacother. 2025. Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male mice. doi:10.1016/j.biopha.2025.118764 PubMed
  7. [7] Xiaopeng Li et al.. Neurochem Res. 2025. Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential. doi:10.1007/s11064-025-04623-4 PubMed
  8. [8] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
  9. [9] Tiago Nicoliche et al.. Sci Rep. 2024. Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2. doi:10.1038/s41598-024-61662-7 PubMed
  10. [10] JinJin Pei et al.. Ageing Res Rev. 2024. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review. doi:10.1016/j.arr.2024.102393 PubMed
  11. [11] Zhihan Chen et al.. Chin Med. 2024. A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer's disease based on the neuroinflammatory. doi:10.1186/s13020-024-00900-6 PubMed
  12. [12] Faizan Ahmad et al.. Ageing Res Rev. 2024. Evolving therapeutic interventions for the management and treatment of Alzheimer's disease. doi:10.1016/j.arr.2024.102229 PubMed
  13. [13] Anne Suély Pinto Savall et al.. Brain Sci. 2024. Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzheimer Disease Model. doi:10.3390/brainsci14020130 PubMed
  14. [14] Bianca Sânziana Daraban et al.. Molecules. 2024. Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems. doi:10.3390/molecules29174056 PubMed
  15. [15] Li Li et al.. Mini Rev Med Chem. 2024. Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease. doi:10.2174/0113895575263783231009051957 PubMed
  16. [16] Shakeel Ahmed Ansari et al.. Pharm Nanotechnol. 2024. Current Updates on Nanotechnology-based Drug Delivery Platforms for Treating Alzheimer's with Herbal Drugs. doi:10.2174/0122117385335626241204165702 PubMed
  17. [17] Yuan Chen et al.. Phytomedicine. 2023. Fucoxanthin, a marine derived carotenoid, attenuates surgery-induced cognitive impairments via activating Akt and ERK pathways in aged mice. doi:10.1016/j.phymed.2023.155043 PubMed
  18. [18] Haya Hussain et al.. Molecules. 2022. Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs. doi:10.3390/molecules27082468 PubMed
  19. [19] Xinyan Wu et al.. Medicine (Baltimore). 2022. A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer disease. doi:10.1097/MD.0000000000030194 PubMed
  20. [20] Haya Hussain et al.. Biomedicines. 2022. Synthetic Mono-Carbonyl Curcumin Analogues Attenuate Oxidative Stress in Mouse Models. doi:10.3390/biomedicines10102597 PubMed
  21. [21] Massimiliano Cuccioloni et al.. Int J Mol Sci. 2022. Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization. doi:10.3390/ijms23158710 PubMed
  22. [22] Suksan Changlek et al.. Foods. 2022. Curcumin Suppresses Lead-Induced Inflammation and Memory Loss in Mouse Model and In Silico Molecular Docking. doi:10.3390/foods11060856 PubMed
  23. [23] Thanyaphon Phothi et al.. Biomed Rep. 2022. Effects of curcumin and γ-oryzanol solid dispersion on the brain of middle-aged rats. doi:10.3892/br.2022.1542 PubMed
  24. [24] Khatereh Kharazmi et al.. Iran J Med Sci. 2022. Protection against Morphine-Induced Inhibitory Avoidance Memory Impairment in Rat by Curcumin: Possible Role of Nitric Oxide/ cAMP-Response Element Binding Protein … doi:10.30476/IJMS.2022.92131.2339 PubMed
  25. [25] Oana M Dumitrascu et al.. Cells. 2021. Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. doi:10.3390/cells10112926 PubMed
  26. [26] R L Moretti et al.. Res Vet Sci. 2021. Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment. doi:10.1016/j.rvsc.2021.09.009 PubMed
  27. [27] Margrethe A Olesen et al.. Redox Biol. 2020. Premature synaptic mitochondrial dysfunction in the hippocampus during aging contributes to memory loss. doi:10.1016/j.redox.2020.101558 PubMed
  28. [28] Yan Xu et al.. Brain Behav. 2020. Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up-regulating SIRT1. doi:10.1002/brb3.1655 PubMed
  29. [29] Chu-Jen Kuo et al.. Phytomedicine. 2019. Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex. doi:10.1016/j.phymed.2018.09.203 PubMed
  30. [30] Pauline da Costa et al.. Environ Toxicol. 2017. Curcumin attenuates memory deficits and the impairment of cholinergic and purinergic signaling in rats chronically exposed to cadmium. doi:10.1002/tox.22213 PubMed
  31. [31] Fu-Chun Zhao et al.. Med Sci Monit. 2017. Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia. doi:10.12659/msm.901842 PubMed
  32. [32] Jessica E Beilharz et al.. Nutrients. 2015. Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions. doi:10.3390/nu7085307 PubMed
  33. [33] Christopher Millington et al.. Biomed Res Int. 2014. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs. doi:10.1155/2014/309129 PubMed
  34. [34] D Sheeja Malar et al.. Curr Pharm Biotechnol. 2014. Dietary polyphenols for treatment of Alzheimer's disease--future research and development. doi:10.2174/1389201015666140813122703 PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。